Stay updated with breaking news from Accurium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Curium, Curium’s 14 Million Patients to Benefit From Regular Supply of Mo-99 and Tc-99
Forecast of no further supply chain challenges for nuclear medicine industry...
Additional production runs and increased processing for the benefit of patientsPARIS, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Curium, the world's leading nuclear medicine company, announced today that with the
Investegate announcements from Curium, Curium’s Customers to Benefit From Mo-99 Production Restart
ST. LOUIS, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Curium, the world's leading nuclear medicine company, announced today that it intends to submit updated labeling to the U.S. Food and Drug Administration (FDA)